vimarsana.com
Home
Live Updates
CRISPR gene editing shows promise for treating individuals with a form of inherited blindness : vimarsana.com
CRISPR gene editing shows promise for treating individuals with a form of inherited blindness : vimarsana.com
CRISPR gene editing shows promise for treating individuals with a form of inherited blindness
Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.
Related Keywords
University Of Pennsylvania ,
Pennsylvania ,
United States ,
Philadelphia ,
Mark Pennesi ,
Irene Heinz ,
Tomass Aleman ,
Baisong Mei ,
Harvard Medical School ,
Hospital Of The University Pennsylvania ,
Cell Therapy Institute ,
Editas Medicine Inc ,
Wk Kellogg Eye Center ,
Scheie Eye Institute ,
Bascom Palmer Eye Institute ,
Ocular Genomics Institute ,
Eric Pierce ,
Mass Eye ,
Mass General Brigham ,
Editas Medicine ,
New England Journal ,
Berman Gund Laboratory ,
Retinal Degenerations ,
Harvard Medical ,
Leber Congenital Amaurosis ,
Chief Medical Officer ,
General Brigham ,
Casey Eye Institute ,
Oregon Health ,
Science University ,
Eye Center ,
Irene Heinz Given ,
John Laporte Research Professor ,
Penn Medicine ,
Blindness ,
Linical Trial ,
Ene ,
As9 ,
Hildren ,
Rispr ,
Ar ,
Fficacy ,
Ye ,
Ood ,
Ene Therapy ,
Ene Editing ,
Enetic ,
Enome ,
Enome Editing ,
Enomics ,
Ealthcare ,
Earing ,
Ospital ,
Aboratory ,
Eber Congenital Amaurosis ,
Edical School ,
Edicine ,
Eck ,
Phthalmology ,
Rotein ,
Esearch ,
Retinal Degeneration ,
Hroat ,
Ision Loss ,